KMPR: A 60%-down insurance company trading near tangible book with a fixable, hard-capped problem that nobody's heard of

Target Price: $50 Kemper Corporation (KMPR, $26.15, $1.5B market cap) is a specialty auto insurer that got obliterated when California doubled its minimum auto liability limits in January 2025 — the first increase since 1967. But the problem is mathematically bounded, rate increases are already in motion, and the stock is pricing near-permanent impairment that almost certainly won't materialize.

What actually happened:

California Senate Bill 1107 raised the minimum bodily injury coverage from $15K to $30K per person and property damage from $5K to $15K. Kemper specializes in minimum-limits drivers — about 90% of their California book. When the limits doubled, something the board didn't anticipate happened: lawyer involvement skyrocketed.

At $15K limits, a lawyer taking 33% got $5K max. Most fender-benders weren't worth a lawyer's time. At $30K, that same accident is worth $10K to a lawyer. Now lawyers are showing up on claims they used to ignore. Kemper's CFO said a represented claim costs 4–5x more than an unrepresented one. The loss ratio went from ~70% to ~88% in four quarters. The combined ratio hit 107%.

This is not fraud. It's not a broken business model. It's a one-time regulatory shock that changed the economics of litigation on minimum-limits claims. The claims are still capped — $30K per person is a hard ceiling. This is a pricing problem, not an existential one.

The fix is already happening:

Rate increases are being approved. Filing 1 (6.9% on 2/3 of the California book) went effective April 6, 2026. Filing 2 (3% on the remainder) goes effective in June. Four total filings are planned for 2026. All California policies are 6-month terms, so rate earns in over 12 months.

Meanwhile, the CEO who presided over this mess was fired. The Board ran a 7-month search and hired Stephen McAnena — a career actuary (25+ years at Liberty Mutual, personal lines president at Farmers, COO at Horace Mann during their record earnings year). He starts Monday, June 1. His comp is 60% performance shares with 3-year ROE targets — aligned, but worth watching since the fastest way to hit an ROE target in insurance is under-reserving.

The rest of the business is fine:

Commercial auto: 92.4% combined ratio, 23% CAGR since 2019, just crossed $1B in trailing premiums for the first time. Florida and Texas personal auto: 93.7% combined ratio, growing. Life insurance: $18M/quarter, steady. Net investment income: $107M/quarter from an $8.7B portfolio of investment-grade fixed income.

California is 63% of P&C premiums — nearly half the company. But the non-CA business is profitable and growing.

The balance sheet is not close to breaking:

Tangible equity (equity minus $1.25B in goodwill): ~$1,430M. Tangible BVPS: $24.38. Stock at $26.15 = 1.07x tangible book. Available liquidity: $750M–$1B+. Operating cash flow: $585M last year. Annual dividend: $82M. Even in a bad scenario where California takes 2+ years to fix, the company has years of runway.

The reserving question is the real risk. Under the prior CEO, three consecutive years of adverse development ($265.6M total) showed systematic under-reserving. But in mid-2023, they changed the reserving methodology. The post-change vintages (AY 2024–2025) are developing favorably — personal auto at −6.7%, commercial auto at −1.9%. The fix appears to be working. It's not proven yet (the vintages are young), but the direction is right.

Mercury General already proved recovery is possible:

MCY is ~80% California and had a 119.2% combined ratio a year ago — far worse than Kemper ever hit. Today their combined ratio is 89.3%. The stock doubled. Same regulatory environment. Same market. Kemper is just 6–12 months behind on the same recovery curve, but their book is lower-end (minimum-limits), which is why the pain was delayed.

Bull case in bullets:

• Problem is a one-time regulatory step-change with a $30K hard cap per person — severity cannot compound upward indefinitely * Rate increases already approved and earning in; 4 filings planned for 2026, compounding to ~27% cumulative * New CEO is an actuary (exactly the right skillset) with turnaround experience at Horace Mann, starts Monday * Post-change reserves are developing favorably (the reserving fix appears real) * Non-CA business is healthy and growing; investment income provides a floor * Short-tail auto — margins should correct in 18–24 months as rate fully earns in * $750M–$1B+ liquidity; dividend is cushioned by $585M operating cash flow * MCY template: same problem, same market, already recovered * Neglect premium: $1.5B market cap, no analyst coverage buzz, no short reports, nobody's heard of this

Bear case (honestly):

• New CEO is unproven, hasn't bought stock yet (watch for insider purchases in the first 90 days) * Reserving posture under prior management was systematically optimistic — the fix needs more quarters to prove itself * If California DOI turns hostile on rate approvals, the recovery timeline extends materially * Commercial auto is only 45% paid on recent vintages — more uncertainty than personal auto * The 4.9% dividend is not covered by current GAAP earnings; a cut could trigger forced selling and a Klarman-style entry opportunity at $15–18

Bottom line: At 1.07x tangible book with a hard-capped problem, rate increases in motion, a new actuary-CEO, and a proven recovery template from Mercury General, this is a favorable-asymmetry bet with a 12–24 month catalyst timeline. It's the kind of situation that's too small, too boring, and too messy for institutional capital to bother with — which is exactly why it's mispriced.